Hadasit Medical Research Services & Development Ltd.;Kahr Medical Ltd.
发明人:
Dranitzki Elhalel, Michal
申请号：
AU2011309689
公开号：
AU2011309689B2
申请日:
2011.09.28
申请国别(地区):
AU
年份:
2015
代理人:
摘要：
Use of a chimeric protein selected from the group consisting of CTLA4- FasL and CD40-FasL proteins for treatment of lymphoma and/or a multiple myeloma and/or a leukemia as described herein, and pharmaceutical compositions and methods of treatment thereof.
